Theralase Technologies Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TLTFF research report →
About the company
Theralase Technologies Inc. , founded in Toronto, Canada in 1994, is a clinical-stage pharmaceutical company focused on the development of innovative therapies and medical devices. The company's pharmaceutical division specializes in the research and development of photo dynamic compounds (PDCs) and their drug formulations.
- CEO
- Roger John Dumoulin-White
- IPO
- 2010
- Employees
- 14
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $53.22M
- P/E
- -18.18
- P/S
- 77.90
- P/B
- 35.37
- EV/EBITDA
- -19.38
- Div Yield
- 0.00%
- Gross Margin
- 51.14%
- Op Margin
- -433.40%
- Net Margin
- -429.11%
- ROE
- -241.53%
- ROIC
- -156.13%
- Revenue
- $816.47K · -20.99%
- Net Income
- $-4,120,817 · 3.18%
- EPS
- $-0.02 · 9.60%
- Op Income
- $-4,175,338
- FCF YoY
- 0.34%
- 52W High
- $0.31
- 52W Low
- $0.10
- 50D MA
- $0.19
- 200D MA
- $0.17
- Beta
- 0.59
- Avg Volume
- 192.23K
Get TickerSpark's AI analysis on TLTFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TLTFF coverage
Recent articles, reports, and earnings notes.
No research on TLTFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TLTFF report →Similar companies
Peers in the same neighborhood.